Fabtech Technologies Secures ₹31.23 Cr Botswana Vaccine Facility Project

Fabtech Technologies Limited (FTL) has secured a ₹31.23 crore contract for the internal infrastructure of a Veterinary Vaccine Manufacturing Facility in Botswana. This project aims to enhance Southern Africa's vaccine manufacturing capacity, supporting animal health and food security. FTL will deliver GMP-compliant internal infrastructure, HVAC, clean utilities, and MEP services. The contract strengthens FTL's presence in Africa's healthcare and biotechnology sectors, aligning with the continent's goal of vaccine self-sufficiency.